Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy

BACKGROUND: In cervical cancer patients with intermediate-risk factors, the optimal adjuvant therapy is still controversial. We undertook a randomized trial (ClinicalTrials.gov Identifier: NCT01418859) to compare the efficacy and toxicity of concurrent chemoradiotherapy with topotecan and cisplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wenze, Wang, Tao, Shi, Fan, Wang, Jiquan, Wang, Juan, Hui, Beina, Zhang, Yingbing, Lu, Jinli, Chen, Hongwei, Liu, Zi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425857/
https://www.ncbi.nlm.nih.gov/pubmed/25935645
http://dx.doi.org/10.1186/s12885-015-1355-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425857/
https://www.ncbi.nlm.nih.gov/pubmed/25935645
http://dx.doi.org/10.1186/s12885-015-1355-1

Ejemplares similares